Jim Simons’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Jim Simons’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-53,600	Closed	-$21K	–	4572
2022 Q4	$21K	Buy	53,600 +5,600	+12%	+$3.63K	﹤0.01%	3956
2022 Q3	$48K	Buy	48,000 +9,899	+26%	+$13.3K	﹤0.01%	3771
2022 Q2	$42K	Buy	+38,101	New	+$87K	﹤0.01%	4022

Jim Simons's AYLA Position: Q1 2023 in Review

Jim Simons sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 53,600 shares — an estimated $21K sold.

Jim Simons first reported a position in AYLA in Q2 2022 and held it in 3 quarters. The position peaked at $48K in Q3 2022. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

Jim Simons reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Jim Simons sold 53,600 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $21K.
Jim Simons first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Jim Simons's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $48K in Q3 2022.
0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.